메뉴 건너뛰기




Volumn 54, Issue 1, 1997, Pages 49-55

Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOPENTHIXOL DECANOATE; FLUPENTIXOL DECANOATE; FLUPHENAZINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; HALOPERIDOL DECANOATE; LOXAPINE; NEUROLEPTIC AGENT; PERPHENAZINE; PIMOZIDE; PSYCHOTROPIC AGENT; THIORIDAZINE;

EID: 0031013410     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830130055011     Document Type: Article
Times cited : (226)

References (55)
  • 2
    • 0001875379 scopus 로고    scopus 로고
    • Drugs and the treatment of psychiatric disorders: Antipsychotic and antianxiety agents
    • Harden W, Rudin W, Molinoff PB, Rall T, eds. New York, NY: McGraw-Hill Book Co
    • Baldessarini RJ. Drugs and the treatment of psychiatric disorders: antipsychotic and antianxiety agents. In: Harden W, Rudin W, Molinoff PB, Rall T, eds. Goodman and Gilman's the Pharmacologic Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill Book Co; 1996:399-430.
    • (1996) Goodman and Gilman's the Pharmacologic Basis of Therapeutics. 9th Ed. , pp. 399-430
    • Baldessarini, R.J.1
  • 3
    • 0028916857 scopus 로고
    • Neuroleptic withdrawal in schizophrenic patients: A review of the literature
    • Gilbert PL, Harris MJ, Jeste DV. Neuroleptic withdrawal in schizophrenic patients: a review of the literature. Arch Gen Psychiatry. 1995;2:173-188.
    • (1995) Arch Gen Psychiatry , vol.2 , pp. 173-188
    • Gilbert, P.L.1    Harris, M.J.2    Jeste, D.V.3
  • 4
    • 0023873890 scopus 로고
    • Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses
    • Baldessarini RJ, Cohen BM, Teicher MH. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry. 1988;45:79-91.
    • (1988) Arch Gen Psychiatry , vol.45 , pp. 79-91
    • Baldessarini, R.J.1    Cohen, B.M.2    Teicher, M.H.3
  • 5
    • 0026410773 scopus 로고
    • Optimal dose of neuroleptic in acute schizophrenia: Controlled study of the neuroleptic threshold and higher haloperidol dose
    • McEvoy JP, Hogarty GE, Steingard S. Optimal dose of neuroleptic in acute schizophrenia: controlled study of the neuroleptic threshold and higher haloperidol dose. Arch Gen Psychiatry. 1991;48:739-745.
    • (1991) Arch Gen Psychiatry , vol.48 , pp. 739-745
    • McEvoy, J.P.1    Hogarty, G.E.2    Steingard, S.3
  • 7
    • 0028235820 scopus 로고
    • Lower-dose therapy with traditional neuroleptics in chronically hospitalized schizophrenic patients
    • Smith RC. Lower-dose therapy with traditional neuroleptics in chronically hospitalized schizophrenic patients. Arch Gen Psychiatry. 1994;51:427-429.
    • (1994) Arch Gen Psychiatry , vol.51 , pp. 427-429
    • Smith, R.C.1
  • 10
    • 0027322643 scopus 로고
    • Continuous vs intermittent neuroleptic therapy in schizophrenia
    • Jolley AG, Hirsch SR. Continuous vs intermittent neuroleptic therapy in schizophrenia. Drug Saf. 1993;8:331-339.
    • (1993) Drug Saf. , vol.8 , pp. 331-339
    • Jolley, A.G.1    Hirsch, S.R.2
  • 12
    • 0002629884 scopus 로고
    • Atypical antipsychotic drugs
    • Bloom FE, Kupfer DJ, eds. New York, NY: Raven Press
    • Meltzer HY. Atypical antipsychotic drugs. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the Fourth Generation of Progress. New York, NY: Raven Press; 1995:1277-1286.
    • (1995) Psychopharmacology: the Fourth Generation of Progress , pp. 1277-1286
    • Meltzer, H.Y.1
  • 13
    • 0028070548 scopus 로고
    • The continuing unethical use of placebo controls
    • Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med. 1994;331:294-298.
    • (1994) N Engl J Med , vol.331 , pp. 294-298
    • Rothman, K.J.1    Michels, K.B.2
  • 14
    • 0028913007 scopus 로고
    • Use of placebo controls in clinical trials disputed
    • Taubes G. Use of placebo controls in clinical trials disputed. Science. 1995;267:25-26.
    • (1995) Science , vol.267 , pp. 25-26
    • Taubes, G.1
  • 15
    • 0029264053 scopus 로고
    • Neuroleptic withdrawal in schizophrenic patients
    • Baldessarini RJ, Viguera AC. Neuroleptic withdrawal in schizophrenic patients. Arch Gen Psychiatry. 1995;52:189-192.
    • (1995) Arch Gen Psychiatry , vol.52 , pp. 189-192
    • Baldessarini, R.J.1    Viguera, A.C.2
  • 16
    • 0029270038 scopus 로고
    • Considering neuroleptic maintenance and taper on a continuum: Need for individual rather than dogmatic approach
    • Jeste DV, Gilbert PL, McAdams LA, Harris MJ. Considering neuroleptic maintenance and taper on a continuum: need for individual rather than dogmatic approach. Arch Gen Psychiatry. 1995;52:209-212.
    • (1995) Arch Gen Psychiatry , vol.52 , pp. 209-212
    • Jeste, D.V.1    Gilbert, P.L.2    McAdams, L.A.3    Harris, M.J.4
  • 17
    • 0029774562 scopus 로고    scopus 로고
    • Lithium withdrawal in bipolar disorder: Implications for clinical practice and experimental therapeutics research
    • Baldessarini RJ, Suppes T, Tondo L. Lithium withdrawal in bipolar disorder: implications for clinical practice and experimental therapeutics research. Am J Ther. 1996;3:492-496.
    • (1996) Am J Ther. , vol.3 , pp. 492-496
    • Baldessarini, R.J.1    Suppes, T.2    Tondo, L.3
  • 18
    • 0002715423 scopus 로고
    • Benzodiazepines: A risk-benefit profile
    • Lader M. Benzodiazepines: a risk-benefit profile. CNS Drugs. 1994;1:377-387.
    • (1994) CNS Drugs , vol.1 , pp. 377-387
    • Lader, M.1
  • 19
    • 0025057283 scopus 로고
    • Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena
    • Dilsaver SC. Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:137-161.
    • (1990) Prog Neuropsychopharmacol Biol Psychiatry , vol.14 , pp. 137-161
    • Dilsaver, S.C.1
  • 20
    • 0026339062 scopus 로고
    • Risk of recurrence following discontinuation of lithium treatment in bipolar disorder
    • Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry. 1991;48:1082-1088.
    • (1991) Arch Gen Psychiatry , vol.48 , pp. 1082-1088
    • Suppes, T.1    Baldessarini, R.J.2    Faedda, G.L.3    Tohen, M.4
  • 21
  • 25
    • 15644384246 scopus 로고
    • Sudden removal of tranquilizing drugs from chronic psychiatric patients
    • Olson GW, Peterson DB. Sudden removal of tranquilizing drugs from chronic psychiatric patients. J Nerv Ment Dis. 1960;131:252-255.
    • (1960) J Nerv Ment Dis. , vol.131 , pp. 252-255
    • Olson, G.W.1    Peterson, D.B.2
  • 26
    • 0342412947 scopus 로고
    • Withdrawal of perphenazine in chronic schizophrenia
    • Whittaker CB, Hoy RM. Withdrawal of perphenazine in chronic schizophrenia. Br J Psychiatry. 1963;109:422-427.
    • (1963) Br J Psychiatry , vol.109 , pp. 422-427
    • Whittaker, C.B.1    Hoy, R.M.2
  • 28
    • 0013942220 scopus 로고
    • Differential effects of abrupt vs gradual withdrawal of chlorpromazine in hospitalized schizophrenic patients
    • Greenberg LM, Roth S. Differential effects of abrupt vs gradual withdrawal of chlorpromazine in hospitalized schizophrenic patients. Am J Psychiatry. 1966;123:221-226.
    • (1966) Am J Psychiatry , vol.123 , pp. 221-226
    • Greenberg, L.M.1    Roth, S.2
  • 29
    • 0014039972 scopus 로고
    • Phenothiazines in prevention of psychiatric hospitalization: Delay or prevention of hospitalization, a reevaluation
    • Engelhardt DM, Rosen B, Freedman N, Margolis R. Phenothiazines in prevention of psychiatric hospitalization: delay or prevention of hospitalization, a reevaluation. Arch Gen Psychiatry. 1967;16:98-101.
    • (1967) Arch Gen Psychiatry , vol.16 , pp. 98-101
    • Engelhardt, D.M.1    Rosen, B.2    Freedman, N.3    Margolis, R.4
  • 30
    • 0014530745 scopus 로고
    • Relapse in chronic schizophrenics following abrupt withdrawal of tranquilizing medication
    • Prien RF, Cole JO, Belkin NF. Relapse in chronic schizophrenics following abrupt withdrawal of tranquilizing medication. Br J Psychiatry. 1969;115:679-686.
    • (1969) Br J Psychiatry , vol.115 , pp. 679-686
    • Prien, R.F.1    Cole, J.O.2    Belkin, N.F.3
  • 31
    • 84970838697 scopus 로고
    • Trial of maintenance therapy in schizophrenia
    • Leff JP, Wing JK. Trial of maintenance therapy in schizophrenia, Br J Psychiatry. 1971;11:599-604.
    • (1971) Br J Psychiatry , vol.11 , pp. 599-604
    • Leff, J.P.1    Wing, J.K.2
  • 32
    • 0016199194 scopus 로고
    • Drug and sociotherapy in the aftercare of schizophrenic patients: Two-year relapse rate
    • Hogarty GE, Goldberg SC, Schooler NR, Ulrich RF. Drug and sociotherapy in the aftercare of schizophrenic patients: two-year relapse rate. Arch Gen Psychiatry. 1974;31:603-608.
    • (1974) Arch Gen Psychiatry , vol.31 , pp. 603-608
    • Hogarty, G.E.1    Goldberg, S.C.2    Schooler, N.R.3    Ulrich, R.F.4
  • 35
    • 0019419898 scopus 로고
    • Schizophrenics fully remitted on neuroleptics for 3-5 years - to stop or continue drugs?
    • Cheung HK. Schizophrenics fully remitted on neuroleptics for 3-5 years - to stop or continue drugs? Br J Psychiatry. 1981;138:490-494.
    • (1981) Br J Psychiatry , vol.138 , pp. 490-494
    • Cheung, H.K.1
  • 36
    • 0028265095 scopus 로고
    • Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia
    • van Kammen DP, Agren H, Yao JK, O'Connor DT, Gurklis J, Peters JL. Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia. Am J Psychiatry. 1994;51:379-384.
    • (1994) Am J Psychiatry , vol.51 , pp. 379-384
    • Van Kammen, D.P.1    Agren, H.2    Yao, J.K.3    O'Connor, D.T.4    Gurklis, J.5    Peters, J.L.6
  • 38
    • 0019474555 scopus 로고
    • Effects of neuroleptic adjustment on clinical condition in tardive dyskinesia in schizophrenic patients
    • Branchey MH, Branchey LB, Richardson MA. Effects of neuroleptic adjustment on clinical condition in tardive dyskinesia In schizophrenic patients. Am J Psychiatry. 1981;138:608-612.
    • (1981) Am J Psychiatry , vol.138 , pp. 608-612
    • Branchey, M.H.1    Branchey, L.B.2    Richardson, M.A.3
  • 40
    • 0018846798 scopus 로고
    • Do schizophrenics well adapted in the community need neuroleptics? a depot withdrawal study
    • Dencker SJ, Lepp M, Malm U. Do schizophrenics well adapted in the community need neuroleptics? a depot withdrawal study. Acta Psychiatr Scand. 1980;61(suppl 279):64-76.
    • (1980) Acta Psychiatr Scand , vol.61 , Issue.SUPPL. 279 , pp. 64-76
    • Dencker, S.J.1    Lepp, M.2    Malm, U.3
  • 41
    • 0019512265 scopus 로고
    • A depot neuroleptic withdrawal study: A controlled study of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients
    • Wistedt B. A depot neuroleptic withdrawal study: a controlled study of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients. Acta Psychiatr Scand. 1981;64:65-84.
    • (1981) Acta Psychiatr Scand , vol.64 , pp. 65-84
    • Wistedt, B.1
  • 42
    • 0026497409 scopus 로고
    • Discontinuation in the very stable schizophrenic patient: Relapse rates and serum neuroleptic levels
    • Sampath G, Shah A, Krska J, Soni SD. Discontinuation in the very stable schizophrenic patient: relapse rates and serum neuroleptic levels. Hum Psychopharmacol. 1992;7:255-264.
    • (1992) Hum Psychopharmacol , vol.7 , pp. 255-264
    • Sampath, G.1    Shah, A.2    Krska, J.3    Soni, S.D.4
  • 43
    • 0000336139 scopus 로고
    • Regression models and life tables
    • Cox DR. Regression models and life tables. J R Stat Soc Ser B. 1972;34:187-220.
    • (1972) J R Stat Soc Ser B , vol.34 , pp. 187-220
    • Cox, D.R.1
  • 46
    • 0025748005 scopus 로고
    • Natural history of schizophrenia subtypes
    • Fenton WS, McGlashan TH. Natural history of schizophrenia subtypes. Arch Gen Psychiatry. 1991;48:969-977.
    • (1991) Arch Gen Psychiatry , vol.48 , pp. 969-977
    • Fenton, W.S.1    McGlashan, T.H.2
  • 47
    • 0026755250 scopus 로고
    • The natural course of schizophrenia: A review of first-admission studies
    • Ram R, Bromet EJ, Eaton WW, Pato C, Schwartz JE. The natural course of schizophrenia: a review of first-admission studies. Schizophr Bull. 1992;18:185-207.
    • (1992) Schizophr Bull. , vol.18 , pp. 185-207
    • Ram, R.1    Bromet, E.J.2    Eaton, W.W.3    Pato, C.4    Schwartz, J.E.5
  • 49
    • 0018651504 scopus 로고
    • Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia
    • Baldessarini RJ, Tarsy D. Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia. Int Rev Neurobiol. 1979;21:1-45.
    • (1979) Int Rev Neurobiol. , vol.21 , pp. 1-45
    • Baldessarini, R.J.1    Tarsy, D.2
  • 50
    • 0018221504 scopus 로고
    • Dopaminergic supersensitivity after neuroleptics: Time-course and specificity
    • Müller P, Seeman P. Dopaminergic supersensitivity after neuroleptics: time-course and specificity. Psychopharmacology (Berl). 1978;60:1-11.
    • (1978) Psychopharmacology (Berl) , vol.60 , pp. 1-11
    • Müller, P.1    Seeman, P.2
  • 51
    • 0026002768 scopus 로고
    • Minimal effective dose and relapse - Double-blind trial: Haloperidol decanoate vs placebo
    • Eklund K, Forsman A. Minimal effective dose and relapse - double-blind trial: haloperidol decanoate vs placebo. Clin Neuropharmacol. 1991;14(suppl 2):S7-S17.
    • (1991) Clin Neuropharmacol , vol.14 , Issue.SUPPL. 2
    • Eklund, K.1    Forsman, A.2
  • 54
    • 0026031035 scopus 로고
    • Recent advances in the treatment of acute mania
    • Chou J C-Y. Recent advances in the treatment of acute mania. J Clin Psychopharmacol. 1991;11:3-21.
    • (1991) J Clin Psychopharmacol , vol.11 , pp. 3-21
    • Chou, J.C.-Y.1
  • 55
    • 0027139769 scopus 로고
    • Chronic neuroleptic use in manic depressive illness
    • Sernyk MJ, Woods SW. Chronic neuroleptic use in manic depressive illness. Psychopharmacol Bull. 1993;29:375-381.
    • (1993) Psychopharmacol Bull. , vol.29 , pp. 375-381
    • Sernyk, M.J.1    Woods, S.W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.